After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

"FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drug" was originally created and published by Clinical ...

Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10.

“Both companies are ‘houses of brands’, in other words a collection of well-diversified luxury businesses serving multiple ...

Three years later, health and beauty brand L’Oreal acquired a majority ... but the company also develops over-the-counter medication as well. Sanofi now covers seven major therapeutic areas ...

A line extension of one of Sanofi Indias flagship brand Combiflam, the launch of this new product marks the companys foray into the OTC headache segment in India.On 11 November 2014, Sanofi India ...

Ramesh and Rajeev Juneja of Mankind Pharma fought popular perceptions and made large acquisitions, focussed on specialty ...

In late 2007, levocetirizine (Xyzal), which has been available in European countries since 2001, was launched in the United States by UCB and Sanofi ... OTC market. Importantly, these brands ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 35.6% in the past six months compared with the industry’s decline ...

Regeneron Pharmaceuticals, Inc. REGN provided business and pipeline updates at the 43rd Annual J.P. Morgan Healthcare ...

By 1995, Zantac (Ranitidine) was sold as an over-the-counter drug ... nationwide withdrawal of all brands of this drug, leading to a surge of lawsuits against pharmaceutical companies such as Pfizer, ...